Since Latinos have the highest prevalence of the PNPLA3-I148M variant [34–36] and the highest rates of NAFLD in the U.S. [6–10], there should be more research studies that focus on this high-risk, understudied population. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.